58
Participants
Start Date
August 14, 2023
Primary Completion Date
March 1, 2024
Study Completion Date
June 1, 2024
Study Product, THC Product, Placebo
Participants will complete up to a seven week study consisting of screening period, baseline period, up to a 21-day product use period with a total of 9 product use sessions. Screening assessments, baseline questions, product use period questionnaires, adverse event reporting, and end of study experience survey data will be collected. This study will be conducted remotely and will use a web-based data collection platform, Consumer Health Learning and Organizing Ecosystem (Chloe), by People Science where participants will complete study assessments using the Chloe app during the course of the study. Participants will receive the study product during the baseline period. Demographic and medical history data will be collected for the study.
RECRUITING
People Science, Inc., Los Angeles
Lead Sponsor
People Science, Inc.
INDUSTRY
Phylos Bioscience, Inc.
INDUSTRY